Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +58.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed +246.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -68.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current ratio changed -69.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -4136 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -360 basis points from the comparable as-filed period.
Cash & equivalents changed -78.4% from the comparable as-filed period.
Research & development changed +30.1% from the comparable as-filed period.
Inventory / revenue changed +1065 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +483 basis points from the comparable as-filed period.
Stock-based compensation changed +103.4% from the comparable as-filed period.
Trade receivables changed +38.0% from the comparable as-filed period.
Revenue changed +15.5% from the comparable as-filed period.
Total assets changed +11.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross debt changed -100.0% from the comparable as-filed period.
Net debt changed -57.0% from the comparable as-filed period.
Reported total debt changed -100.0% from the comparable as-filed period.
Operating income changed -12.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +1468 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed +297 basis points from the comparable as-filed period.
Gross profit changed +15.8% from the comparable as-filed period.
Net income changed -15.7% from the comparable as-filed period.
Debt / assets changed -3587 basis points from the comparable as-filed period.
Gross margin changed +24 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / revenue changed -31432 basis points from the comparable as-filed period.
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
Cost of revenue changed +14.2% from the comparable as-filed period.
Current assets changed +5.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.